Fabio Canino
Modena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Time to next treatment to evaluate the therapeutic sequence after first- or second-line CDK4/6 inhibitors of hormone receptor-positive, HER2-negative advanced breast cancer in Italy: a retrospective/prospective observational trial GOIRC-04-2019.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
Trastuzumab-deruxtecan (T-DXd) in HER2+ metastatic breast cancer: efficacy, clinical management, and perspectives
Journal: Recenti progressi in medicina
Published: January 22, 2026
Impact of Ethnicity on Breast Cancer Outcome: A Systematic Review and Meta-Analysis of Randomized Phase III Trials of the Last Decade.
Journal: JCO global oncology
Published: July 01, 2025
Role of Pectoralis Muscle Analysis in Breast Magnetic Resonance Imaging for Body Composition Evaluation Before and After Neoadjuvant Chemotherapy for Breast Cancer.
Journal: Nutrients
Published: March 30, 2025
Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments.
Journal: Breast cancer (Dove Medical Press)
Published: August 23, 2024
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2-positive early breast cancer: real-world data from NeoPowER study.
Journal: BMC cancer
Published: March 03, 2024
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients.
Journal: International journal of molecular sciences
Published: January 16, 2024
Enhancing the nutritional value of sweet bell pepper through moderate NaCl salinity.
Journal: Heliyon
Published: July 18, 2023
Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis.
Journal: Clinical breast cancer
Published: December 13, 2022
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Journal: British journal of cancer
Published: December 02, 2022
Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges.
Journal: Biomedicines
Published: November 27, 2022
Last Updated: 09/26/2026